238 related articles for article (PubMed ID: 12579319)
41. Scintimammography with a high resolution dedicated breast camera in comparison with SPECT/CT in primary breast cancer detection.
Spanu A; Chessa F; Sanna D; Cottu P; Manca A; Nuvoli S; Madeddu G
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):271-80. PubMed ID: 18596669
[TBL] [Abstract][Full Text] [Related]
42. L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observations.
Jager PL; Groen HJ; van der Leest A; van Putten JW; Pieterman RM; de Vries EG; Piers DA
J Nucl Med; 2001 Apr; 42(4):579-85. PubMed ID: 11337545
[TBL] [Abstract][Full Text] [Related]
43. Improvement of non-small-cell lung cancer staging by means of positron emission tomography.
Albes JM; Lietzenmayer R; Schott U; Schülen E; Wehrmann M; Ziemer G
Thorac Cardiovasc Surg; 1999 Feb; 47(1):42-7. PubMed ID: 10218620
[TBL] [Abstract][Full Text] [Related]
44. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A
Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098
[TBL] [Abstract][Full Text] [Related]
45. Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer.
Everaert H; Flamen P; Franken PR; Verhaeghe W; Bossuyt A
Anticancer Res; 1997; 17(3B):1577-82. PubMed ID: 9179197
[TBL] [Abstract][Full Text] [Related]
46. The role of 99mTc-tetrofosmin scintigraphy for staging patients with laryngeal cancer.
Fattori B; Grosso M; Nacci A; Bianchi F; Cosottini M; Ursino F; Manca G; Rubello D; Strauss HW; Mariani G
Cancer Biother Radiopharm; 2005 Feb; 20(1):27-35. PubMed ID: 15778576
[TBL] [Abstract][Full Text] [Related]
47. (99m)Tc-3P-RGD2 SPECT to monitor early response to bevacizumab therapy in patients with advanced non-small cell lung cancer.
Chen B; Zhao G; Ma Q; Ji B; Ji T; Xin H; Gao S
Int J Clin Exp Pathol; 2015; 8(12):16064-72. PubMed ID: 26884883
[TBL] [Abstract][Full Text] [Related]
48. Detection of malignant thymoma in primary tumor and metastatic lesions using 99mTc-tetrofosmin scintigraphy.
Hashimoto T; Takahashi K; Goto M; Endo H; Kono T; Nishiyama H; Iimura F; Kuwashima S; Sawada H; Saiki N; Yamato M; Fujioka M
Radiat Med; 2001; 19(3):169-72. PubMed ID: 11467386
[TBL] [Abstract][Full Text] [Related]
49. Sentinel node identification in clinical stage Ia non-small cell lung cancer by a combined single photon emission computed tomography/computed tomography system.
Nomori H; Ikeda K; Mori T; Shiraishi S; Kobayashi H; Iwatani K; Kawanaka K; Kobayashi T
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):182-7. PubMed ID: 17599506
[TBL] [Abstract][Full Text] [Related]
50. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
[TBL] [Abstract][Full Text] [Related]
51. Lymphoscintigraphy in early-stage non-small cell lung cancer with technetium-99m nanocolloids and hybrid SPECT/CT: a pilot project.
Abele JT; Allred K; Clare T; Bédard EL
Ann Nucl Med; 2014 Jun; 28(5):477-83. PubMed ID: 24557659
[TBL] [Abstract][Full Text] [Related]
52. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Bryant AS; Cerfolio RJ
Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
[TBL] [Abstract][Full Text] [Related]
53. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Eloubeidi MA; Cerfolio RJ; Chen VK; Desmond R; Syed S; Ojha B
Ann Thorac Surg; 2005 Jan; 79(1):263-8. PubMed ID: 15620955
[TBL] [Abstract][Full Text] [Related]
54. The role of 99mTc-tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node staging.
Spanu A; Dettori G; Chiaramida P; Cottu P; Falchi A; Porcu A; Solinas ME; Nuvoli S; Madeddu G
Cancer Biother Radiopharm; 2000 Feb; 15(1):81-91. PubMed ID: 10740656
[TBL] [Abstract][Full Text] [Related]
55. Imaging of regional lymph node metastases with 99mTc-depreotide in patients with lung cancer.
Danielsson R; Bååth M; Svensson L; Forslöv U; Kölbeck KG
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):925-31. PubMed ID: 15841374
[TBL] [Abstract][Full Text] [Related]
56. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
[TBL] [Abstract][Full Text] [Related]
57. 99mTc-EDDA/HYNIC-Tyr(3)-octreotide for staging and follow-up of patients with neuroendocrine gastro-entero-pancreatic tumors.
Gabriel M; Muehllechner P; Decristoforo C; von Guggenberg E; Kendler D; Prommegger R; Profanter C; Moncayo R; Virgolini I
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):237-44. PubMed ID: 16172569
[TBL] [Abstract][Full Text] [Related]
58. Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.
Stevens H; Bakker PF; Schlösser NJ; van Rijk PP; de Klerk JM
J Nucl Med; 2003 Mar; 44(3):336-40. PubMed ID: 12620997
[TBL] [Abstract][Full Text] [Related]
59. 99mTC-tetrofosmin scintigraphy in lung carcinoma staging and follow-up evaluations.
Buccheri G; Biggi A; Ferrigno D; Francini A
Cancer; 2002 Mar; 94(6):1796-807. PubMed ID: 11920543
[TBL] [Abstract][Full Text] [Related]
60. Scintimammography and single-photon emission computed tomography for postoperative image guidance for radiation treatment planning in breast cancer patients.
Piperkova E; Chavdarova L; Garanina Z; Gocheva L; Parvanova V; Tzonevska A; Dimitrova M
J BUON; 2011; 16(4):657-63. PubMed ID: 22331718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
